301234.SZ
五洲医疗
SZSE · C 制造业 · CN
CNY 110.00
+14.46%Year over year
Reported trailing growth
- Revenue
- -7.5%
- EBITDA
- —
- EBIT
- -38.6%
- EPS
- -40.3%
- Free cash flow
- +19.0%
- Operating cash flow
- -10.5%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -5.7%
- EBITDA
- -9.9%
- EBIT
- -27.6%
- Net income
- -35.7%
- EPS
- -38.5%
- Free cash flow
- +121.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026